Neurological Surgery Doctors in Pinehurst, NC Accepting Medicare

6 Neurological Surgery doctors found. Showing 1 - 6

Teddy Earl Kim, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 10 Aviemore Dr, Pinehurst, NC 28374 Phone: 910-715-8700

Bruce Jaufmann, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 5 First Village Dr, Pinehurst, NC 28374 Phone: 910-295-0215    Fax: 910-295-0218

David B Kee, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 5 First Village Drive, Pinehurst, NC 28374 Phone: 910-295-0215    Fax: 910-295-0218

Dr. James B. Walker, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 10 Aviemore Dr, Pinehurst, NC 28374 Phone: 910-715-8700    Fax: 910-715-8761

Carol M Wadon, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 5 First Vlg, Pinehurst, NC 28374 Phone: 910-295-0215    Fax: 910-295-0218

Cynthia Zane Africk, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 10 Aviemore Dr, Pinehurst, NC 28374 Phone: 910-715-8700    Fax: 910-715-8761

News Archive

Superbug structure deciphered

NDM-1, the enzyme responsible for antibiotic-resistant "superbugs," has had its structure deciphered by British scientists. NDM-1 (New Delhi metallo-beta-lactamase 1) emerged in India three years ago. It has the ability to break up, or hydrolyze, even carbapenems, the strongest class of antibiotics, making them ineffective, and has been found in a wide variety of pathogens. Antibiotic resistance is on the rise. More than 25,000 people in the European Union die every year from bacterial infections.

Clinical trials – how can patients get the most benefit out of them?

Putting patients at the centre of clinical trial research is perhaps something that goes without saying. At the Clinical Innovation and Partnering World congress in London last week, this was much discussed, along with the need to increase efforts into engaging patients to take part in clinical trials, and the fact that patients are sometimes suspicious of research because it is not explained enough and patient engagement is poor.

New thematic issue highlights link between hyperuricemia, gout and kidney disease

The increasing prevalence of both gout and chronic kidney disease has led to a growing interest in the association between hyperuricemia (an abnormally high level of uric acid in the blood) and kidney disease.

Eisai signs agreement with Arena Pharmaceuticals GmbH to commercialize lorcaserin

Eisai Inc., the U.S. pharmaceutical operation of Tokyo-based Eisai Co., Ltd., announced today that it has entered into an agreement with Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., for exclusive U.S. rights to commercialize lorcaserin, a drug candidate for potential use in the treatment of obesity, including weight loss, for patients who are obese (Body Mass Index or BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related co-morbid condition.

Quantum Plastics acquires wheelchair stabilizing device company, Transfer Solutions

Quantum Plastics, LLC (Quantum) is expanding its product line with the acquisition of the popular wheelchair stabilizing device company, Transfer Solutions.

Read more Medical News

› Verified 7 days ago